FDA Approved Products

4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: LOE ApproachingClear all
LORFAN
levallorphan tartrate
LOE Approaching
Roche
INJECTION · INJECTABLE
1956
NDA
30/100
LOTEMAX
loteprednol etabonate
LOE Approaching
Bausch + Lomb
OPHTHALMIC · SUSPENSION/DROPS
steroid-responsive inflammatory conditions of the palpebralbulbar conjunctiva+11
1998
NDA
30/100
LOTEMAX
loteprednol etabonate
LOE Approaching
OPHTHALMIC · SUSPENSION/DROPS
1998
NDA
30/100
LOTEMAX
loteprednol etabonate
LOE Approaching
Bausch + Lomb
OPHTHALMIC · OINTMENT
post-operative inflammationpain following ocular surgery
2011
NDA
30/100
LOTENSIN
benazepril hydrochloride
LOE Approaching
Bausch Health
ORAL · TABLET
hypertensionto lower blood pressure
1991
NDA
30/100
LOTENSIN HCT
benazepril hydrochloride and hydrochlorothiazide
LOE Approaching
Bausch Health
ORAL · TABLET
hypertension
1992
NDA
30/100
LOTREL
amlodipine besylate and benazepril hydrochloride
LOE Approaching
Novartis
ORAL · CAPSULE
hypertension in patients not adequately controlled on monotherapy with either agenthypertension
1995
NDA
30/100
LOTRIMIN
clotrimazole
LOE Approaching
Merck & Co.
TOPICAL · LOTION
1984
SMNDA
30/100
LOTRIMIN
clotrimazole
LOE Approaching
Merck & Co.
TOPICAL · CREAM
1975
SMNDA
30/100
LOTRIMIN
clotrimazole
LOE Approaching
Merck & Co.
TOPICAL · SOLUTION
1975
SMNDA
30/100
LOTRIMIN AF
clotrimazole
LOE Approaching
Merck & Co.
Topical · Lotion
1989
SMNDA
30/100
LOTRIMIN AF
clotrimazole
LOE Approaching
Merck & Co.
Topical · Cream
1989
SMNDA
30/100
LOTRIMIN AF
clotrimazole
LOE Approaching
Merck & Co.
Topical · Solution
1989
SMNDA
30/100
LOTRIMIN ULTRA
butenafine hydrochloride
LOE Approaching
Bayer
TOPICAL · CREAM
2001
NDA
30/100
LOTRISONE
betamethasone dipropionate; clotrimazole
LOE Approaching
Merck & Co.
TOPICAL · CREAM
1984
SMNDA
30/100
LOTRISONE
betamethasone dipropionate; clotrimazole
LOE Approaching
Merck & Co.
TOPICAL · LOTION
2000
SMNDA
30/100
LOTRONEX
alosetron hydrochloride
LOE Approaching
Enterprise Therapeutics
ORAL · TABLET
2000
NDA
30/100
LOTUSATE
talbutal
LOE Approaching
Sanofi
ORAL · TABLET
1954
NDA
30/100
LOVAZA
omega-3-acid ethyl esters
LOE Approaching
Viatris (2)
ORAL · CAPSULE
2004
NDA
30/100
LOVENOX
enoxaparin sodium
LOE Approaching
Sanofi
INTRAVENOUS, SUBCUTANEOUS · INJECTABLE
deep vein thrombosis (DVT)which may lead to pulmonary embolism (PE): in patients undergoing abdominal surgery+4
1993
NDA
30/100
LOVENOX
enoxaparin sodium
LOE Approaching
Sanofi
INJECTION · INJECTABLE
2007
NDA
30/100
LOVENOX (PRESERVATIVE FREE)
enoxaparin sodium
LOE Approaching
Sanofi
SUBCUTANEOUS · INJECTABLE
deep vein thrombosis (DVT)which may lead to pulmonary embolism (PE): in patients undergoing abdominal surgery+4
1993
NDA
30/100
LOXITANE
loxapine succinate
LOE Approaching
Teva
ORAL · TABLET
1975
NDA
30/100
LOXITANE C
loxapine hydrochloride
LOE Approaching
Teva
ORAL · CONCENTRATE
1976
NDA
30/100
← PreviousPage 91 of 188Next →